Join the Enflonsia group to help and get support from people like you.
Enflonsia News
New Antibody Shot, Enflonsia, Could Help Protect Babies From RSV
THURSDAY, June 12, 2025 — A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization in U.S. infants. The U.S. Food and Drug A...
FDA Approves Enflonsia (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants
RAHWAY, N.J.--(BUSINESS WIRE) June 9, 2025 – Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has approved...